Description
The structural changes of the bronchial mucosa in asthma are consequences of cellular interactions. They appear more sluggish than the latter, and they form the basis for the irreversible component of the functional disorder. This underlines the importance of early anti-inflammatory treatment. In this context, interest in theophyllin as a modulator of inflammation has been evoked recently, supported by the latest in vitro and in vivo results.
